Atara Biotherapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

ATRA
Atara Biotherapeutics

Last Price:

10.60

Seasonality Move:

37.22%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Atara Biotherapeutics Price Quote

$10.60

-0.08 (-0.75%)

(Updated: November 21, 2024 at 5:55 PM ET)

Atara Biotherapeutics Key Stats

Sell

Atara Biotherapeutics (ATRA) is a Sell

Day range:

$10.32 - $11.15

52-week range:

$6.50 - $39.50

Dividend yield:

P/E ratio:

0.00

P/S ratio:

0.66

P/B ratio:

Volume:

108.4K

Avg. volume:

125.2K

1-year change:

-23.44%

Market cap:

$65.3M

Revenue:

$8.6M

EPS:

$-25.76

How Much Does Atara Biotherapeutics Make?

How Much Are Atara Biotherapeutics's Sales Annually?
ATRA Revenues are $8.6M
How Much Profit Does Atara Biotherapeutics's Make A Year?
ATRA net income is -$276.1M

Is Atara Biotherapeutics Growing As A Company?

What Is Atara Biotherapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 17.8%
What Is Atara Biotherapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Atara Biotherapeutics Stock Price Performance

Did Atara Biotherapeutics Stock Go Up Last Month?
Atara Biotherapeutics share price went up by 13.5% last month
Did ATRA's Share Price Rise Over The Last Year?
ATRA share price fell by -23.44% over the past 1 year

What Is Atara Biotherapeutics 52-Week High & Low?

What Is Atara Biotherapeutics’s 52-Week High Share Price?
Atara Biotherapeutics has traded as high as $39.50 over the past 52 weeks
What Is Atara Biotherapeutics’s 52-Week Low Share Price?
Atara Biotherapeutics has traded as low as $6.50 over the past 52 weeks

Atara Biotherapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Atara Biotherapeutics?

How Much Debt Does Atara Biotherapeutics Have?
Total long term debt quarterly is $0
How Much Cash Does Atara Biotherapeutics Have?
Cash and short term investments quarterly total is $67.2M
What Is Atara Biotherapeutics’s Book Value Per Share?
Book value per share is -15.77

Is Atara Biotherapeutics Cash Flow Positive?

What Is ATRA Cash Flow From Operations?
Cash flow from operations (TTM) is -$94.7M
What Is Atara Biotherapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $61.1M
What Is Atara Biotherapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $15.2M

Atara Biotherapeutics Return On Invested Capital